NabGen, Inc. is an NC based biotech company developing an antibody suppression platform with broad applications.
NabGen, Inc. has raised $3.0M in total funding. The most recent round was Grant. The last funding was announced in August 2025.
NabGen, Inc.'s investors include North Carolina Biotechnology Center.
NabGen, Inc. is headquartered in Durham, United States.
NabGen, Inc. is an NC based biotech company developing an antibody suppression platform with broad applications.
NabGen, Inc. is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NabGen, Inc. — Funding & Investors." VCBacked, August 15, 2025, https://www.vcbacked.co/company/nabgen-inc. Accessed September 30, 2026.
VCBacked. (2025). NabGen, Inc. — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/nabgen-inc
{{cite web |title=NabGen, Inc. — Funding & Investors |url=https://www.vcbacked.co/company/nabgen-inc |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated